UnknownNot Applicable

An Observational Study on Intermittent Self Catheterisation Discontinuation Factors in Multiple Sclerosis Patients

France225 participantsStarted 2019-06-26

Plain-language summary

Urinary disorders (UD) are common in Multiple Sclerosis (MS) and can necessitate using Intermittent Self Catheterisation (ISC). It is well experienced by patients, has little impact on daily life and improves quality of life. However, studies are lacking on long-term adherence to this treatment as well as on discontinuation factors. Our main objective is to prospectively assessed factors associated with ISC discontinuation 2 years after having introduced this technique.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient aged 18 to 65 years * Patient with MS * First ISC prescription * Patient giving informed consent * Patient affiliated to the social security system Exclusion Criteria: * Patient who has already tried / practiced ISC * Patient under safeguard of justice / guardianship / tutorship * Pregnant or lactating woman

What they're measuring

intermittent self catheterisation discontinuation at 2 years after the start of learning.

Timeframe: 2 years

Trial details

NCT IDNCT04132037

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12

View on ClinicalTrials.gov More Multiple Sclerosis trials